lncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach
- PMID: 36367661
- DOI: 10.1007/s11033-022-08080-y
lncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach
Abstract
Background: Antiphospholipid syndrome (APS) is the main cause of acquired thrombophilia where peripheral circulating cells such as monocytes have a key role. Currently, several studies have linked long non-coding RNAs (lncRNAs) in different inflammatory and autoimmune processes, including lupus. However, the role of lncRNAs in antiphospholipid syndrome is unknown, therefore, we aimed to select and measure expression levels of three lncRNAs based on its abundance in monocytes from APS patients.
Methods: Selection of lncRNAs candidates were carried out based on its abundance in monocytes and their relationship with Perez-Sanchez miRNA signature by using miRNet 2.0 bioinformatic tool, then lncRNAs expression levels was measured in monocytes by RT-qPCR.
Results: This is the first study to report that lncRNAs: FGD5-AS1, OIP5-AS1 and GAS5 are promising candidates for play a role on APS monocytes and they are expressed differently between patients and controls.
Conclusions: OIP5-AS1, FGD5-AS1 and GAS5 are downregulated on monocytes from APS patients.
Keywords: Antiphospholipid syndrome; FGD5-AS1; GAS5; Long noncoding RNAs; Monocytes; OIP5-AS1.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Whole Blood Expression Levels of Long Noncoding RNAs: HOTAIRM1, GAS5, MZF1-AS1, and OIP5-AS1 as Biomarkers in Adolescents with Obesity-Related Asthma.Int J Mol Sci. 2023 Mar 30;24(7):6481. doi: 10.3390/ijms24076481. Int J Mol Sci. 2023. PMID: 37047453 Free PMC article.
-
Expression of Pivotal Long Non-coding RNAs Implicated in Gastric Cancer: A Bioinformatic and Clinical Study.Biochem Genet. 2024 Aug;62(4):3111-3135. doi: 10.1007/s10528-023-10586-4. Epub 2023 Dec 9. Biochem Genet. 2024. PMID: 38070023
-
Long Non-Coding RNA FGD5-AS1 Induced by Chlamydia trachomatis Infection Inhibits Apoptosis via Wnt/β-Catenin Signaling Pathway.Front Cell Infect Microbiol. 2021 Sep 9;11:701352. doi: 10.3389/fcimb.2021.701352. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34568091 Free PMC article.
-
The role of long non-coding RNA FGD5-AS1 in cancer.Bioengineered. 2022 Apr;13(4):11026-11041. doi: 10.1080/21655979.2022.2067292. Bioengineered. 2022. PMID: 35475392 Free PMC article. Review.
-
The role of lncRNA OIP5-AS1 in cancer development and progression.Apoptosis. 2022 Jun;27(5-6):311-321. doi: 10.1007/s10495-022-01722-3. Epub 2022 Mar 22. Apoptosis. 2022. PMID: 35316453 Review.
Cited by
-
Long noncoding RNA MALAT1 in dermatologic disorders: a comprehensive review.Biomark Med. 2024;18(19):853-867. doi: 10.1080/17520363.2024.2369044. Epub 2024 Jul 9. Biomark Med. 2024. PMID: 38982732 Free PMC article. Review.
-
Increased Expression of lncRNA AC000120.7 and SENP3-EIF4A1 in Patients with Acute Respiratory Distress Syndrome Induced by SARS-CoV-2 Infection: A Pilot Study.Microorganisms. 2023 Sep 19;11(9):2342. doi: 10.3390/microorganisms11092342. Microorganisms. 2023. PMID: 37764186 Free PMC article.
-
ARID5B-mediated LINC01128 epigenetically activated pyroptosis and apoptosis by promoting the formation of the BTF3/STAT3 complex in β2GPI/anti-β2GPI-treated monocytes.Clin Transl Med. 2024 Jan;14(1):e1539. doi: 10.1002/ctm2.1539. Clin Transl Med. 2024. PMID: 38224186 Free PMC article.
-
Trophoblast Cell Function in the Antiphospholipid Syndrome.Biomedicines. 2023 Sep 30;11(10):2681. doi: 10.3390/biomedicines11102681. Biomedicines. 2023. PMID: 37893055 Free PMC article. Review.
-
Interaction between Long Noncoding RNAs and Syncytin-1/Syncytin-2 Genes and Transcripts: How Noncoding RNAs May Affect Pregnancy in Patients with Systemic Lupus Erythematosus.Int J Mol Sci. 2023 Jan 23;24(3):2259. doi: 10.3390/ijms24032259. Int J Mol Sci. 2023. PMID: 36768581 Free PMC article.
References
-
- Sayar Z, Moll R, Isenberg D, Cohen H (2020) Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management. Thrombosis Res 198:213–221 - DOI
-
- Miyakis S et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306 - DOI
-
- Juárez-Vicuña Y et al (2021) miR-19b-3p and miR-20a-5p are associated with the levels of antiphospholipid antibodies in patients with antiphospholipid syndrome. Rheumatol Int 41(7):1329–1335 - DOI
-
- Pérez-Sánchez L et al (2021) Characterization of antiphospholipid syndrome atherothrombotic risk by unsupervised integrated transcriptomic analyses. Arterioscler Thromb Vasc Biol 41:865–877 - DOI
-
- Wu GC et al (2015) Emerging role of long noncoding RNAs in autoimmune diseases. Autoimmun Rev 14:798–805 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous